That's fine, and there's something too it. But it doesn't add up to "perilous cash position." It's a normal challenge for a business seeking to develop a highly disruptive technology. I've seen perilous, and this ain't it. I'm deep in perilous with an investment in a privately held company with technology sufficiently disruptive to claim a large part of the entire electronics industry. We claim "the unique state of matter required to integrate electronics." Seeking investors so we can get out of perilous-land forever.
You need to add up the FDA meetings and the progress of FLUCIDE, IV FLUCIDE, and ORAL FLUCIDE,and the potential of an ORPHAN DESIGNATION for immuno compromised patients FLUCIDE.
Those are something.
The burn rate is calculated with the intended actions in there.
News 
Market Data 
Discover 
